Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44

Related Articles by Review for PubMed (Select 15247754)

1.

The efficacy and safety of tadalafil in United States and Puerto Rican men with erectile dysfunction.

Seftel AD, Wilson SK, Knapp PM, Shin J, Wang WC, Ahuja S.

J Urol. 2004 Aug;172(2):652-7. Erratum in: J Urol. 2005 Feb;173(2):664.

PMID:
15247754
2.

Tadalafil.

Curran M, Keating G.

Drugs. 2003;63(20):2203-12; discussion 2213-4. Review. Erratum in: Drugs. 2003;63(23):2703.

PMID:
14498756
3.

Vardenafil: a review of its use in erectile dysfunction.

Keating GM, Scott LJ.

Drugs. 2003;63(23):2673-703. Review.

PMID:
14636086
4.

Efficacy and safety of tadalafil once daily: considerations for the practical application of a daily dosing option.

Donatucci CF, Wong DG, Giuliano F, Glina S, Dowsett SA, Watts S, Sorsaburu S.

Curr Med Res Opin. 2008 Dec;24(12):3383-92. doi: 10.1185/03007990802498440 . Review. Erratum in: Curr Med Res Opin. 2009 Feb;25(2):505. Curr Med Res Opin. 2010 Mar;26(3):632.

PMID:
19032120
5.

Vardenafil (Levitra) for erectile dysfunction: a systematic review and meta-analysis of clinical trial reports.

Markou S, Perimenis P, Gyftopoulos K, Athanasopoulos A, Barbalias G.

Int J Impot Res. 2004 Dec;16(6):470-8. Review.

PMID:
15229625
6.
7.

Erection hardness: a unifying factor for defining response in the treatment of erectile dysfunction.

Mulhall JP, Levine LA, Jünemann KP.

Urology. 2006 Sep;68(3 Suppl):17-25. Review.

PMID:
17011372
8.

Tadalafil in the treatment of erectile dysfunction.

Bella AJ, Brock GB.

Curr Urol Rep. 2003 Dec;4(6):472-8. Review.

PMID:
14622501
9.

Vardenafil: a new approach to the treatment of erectile dysfunction.

Hellstrom WJ.

Curr Urol Rep. 2003 Dec;4(6):479-87. Review.

PMID:
14622502
10.

Stopwatch-assessed duration of erection: a new measure of the efficacy of erectile dysfunction treatments.

Rosenberg MT, Miner MM, Barnes AL, Janning SW.

Int J Impot Res. 2011 Jan-Feb;23(1):9-16. doi: 10.1038/ijir.2010.30. Epub 2010 Dec 23. Review.

PMID:
21179109
11.

Phosphodiesterase 5 inhibitors in male sexual dysfunction.

Kuthe A.

Curr Opin Urol. 2003 Sep;13(5):405-10. Review.

PMID:
12917517
12.

Vardenafil.

Ormrod D, Easthope SE, Figgitt DP.

Drugs Aging. 2002;19(3):217-27; discussion 228-9. Review. Erratum in: Drugs Aging 2002;19(11):886. Drugs Aging. 2003;20(2):140..

PMID:
12027779
13.

Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus.

Vardi M, Nini A.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD002187. Review.

PMID:
17253475
14.

Selective phosphodiesterase type 5 inhibition using tadalafil for the treatment of erectile dysfunction.

Kuan J, Brock G.

Expert Opin Investig Drugs. 2002 Nov;11(11):1605-13. Review.

PMID:
12437506
15.

Cardiovascular effects of tadalafil.

Kloner RA, Mitchell M, Emmick JT.

Am J Cardiol. 2003 Nov 6;92(9A):37M-46M. Review.

PMID:
14609622
16.

[Comparison of efficacy and safety of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction].

Chen Q, Wang N, Yao F, Lu X.

Zhonghua Nan Ke Xue. 2004 Apr;10(4):302-4. Review. Chinese.

PMID:
15148932
17.

IC351 (tadalafil, Cialis): update on clinical experience.

Porst H.

Int J Impot Res. 2002 Feb;14 Suppl 1:S57-64. Review.

18.

Cardiovascular effects of tadalafil in patients on common antihypertensive therapies.

Kloner RA, Mitchell M, Emmick JT.

Am J Cardiol. 2003 Nov 6;92(9A):47M-57M. Review.

PMID:
14609623
19.

[Chronic PDE-5 inhibition in patients with erectile dysfunction: new treatment approach using once daily Tadalafil].

Porst H, Hell-Momeni K, Büttner H.

Urologe A. 2009 Nov;48(11):1318, 1320-9. doi: 10.1007/s00120-009-2089-y. Review. German.

PMID:
19756466
20.

[Erectile dysfunction. New drugs with special consideration of the PDE 5 inhibitors].

Porst H.

Urologe A. 2004 Jul;43(7):820-8. Review. German.

PMID:
15197447
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk